Navigation Links
Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
Date:3/7/2013

ess release to reflect events or circumstances after the date hereof.

Cadence® and OFIRMEV® are trademarks of Cadence Pharmaceuticals, Inc. Contact:

William R. LaRue

Kelli FranceSVP & Chief Financial Officer

Media RelationsCadence Pharmaceuticals, Inc.

WCGPhone: 858-436-1400

Phone: 415-946-1076 CADENCE PHARMACEUTICALS, INC.CONDENSED STATEMENTS OF OPERATIONS(unaudited)(in thousands, except share and per share amounts)Three Months EndedTwelve Months EndedDecember 31,December 31,2012201120122011Revenue:Product revenue, net

$   17,089$
5,889$   50,066$   11,486License revenues

85-1185,210Total revenues

17,1745,88950,18416,696Costs and expenses:Cost of product sales

7,1788,81823,25612,406Amortization of patent license

3353351,3431,567Research and development

1,0731,8836,5198,885Selling, general and administrative

20,03220,50186,84381,504Impairment of long-lived assets

7,723-7,723-Other

1,1601,0771,1741,076Total costs and expenses

37,50132,614126,858105,438Loss from operations

(20,327)(26,725)(76,674)(88,742)Other expense, net

(1,094)(881)(4,299)(4,279)Net loss

$ (21,421)$ (27,606)$ (80,973)$ (93,021)Basic and diluted net loss per share(1)

$
(0.25)$
(0.37)$
(0.95)$
(1.41)Shares used to compute basic anddiluted net loss per share(1)

85,59173,98285,55666,075(1)

There is a lack of comparability in the per share amounts between the periods presented as a result of the issuance of 21,800,000 shares of common stock pursuant to a public offering in November 2011. CADENCE PHARMACEUTICALS, INC.CONDENSED BALANCE SHEETS(in thousands)December 31,December 31,20122011(unaudited)AssetsCurrent assets:Cash, cash equivalents and short-term investments 

$
2,072$
27,227Restrict
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013
2. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
3. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Leerink Swann Global Healthcare Conference In New York City On February 13, 2013
4. Cadence Pharmaceuticals Estimates Fourth Quarter 2012 Net Product Revenue and Provides Full Year 2013 Revenue Guidance
5. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
6. Cadence Pharmaceuticals to Host Analyst and Investor Day
7. Cadence to Open Finished Medical Device Facility
8. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Piper Jaffray 24th Annual Healthcare Conference In New York City On November 28, 2012
9. Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
10. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2012 Financial Results On November 5, 2012
11. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2012 In Boston On September 5, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014  Syneron Medical Ltd. (NASDAQ: ELOS ... that its new PicoWay® device has received CE Mark ... and pigmented lesions on any skin type. PicoWay is ... and 1064nm wavelengths, which utilizes Syneron,s proprietary PicoWay technology ... are trillionths of a second, known as picosecond pulses. ...
(Date:7/28/2014)... Concord Medical Services Holdings Limited ("Concord Medical" ... leading specialty hospital management solution provider and operator of ... in China , today announced that ... a special cash dividend of US$0.30 per ordinary share ... Company,s outstanding ordinary shares. The total expense for the ...
(Date:7/28/2014)...   Cardioxyl Pharmaceuticals, Inc. announced today the ... a novel potential treatment for acute decompensated heart failure ... has now initiated dosing of hospitalized patients with decompensated ... to further evaluate the drug,s safety and tolerability as ... I clinical trial evaluated the safety and tolerability of ...
Breaking Medicine Technology:Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 3Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 4Concord Medical Declares Special Dividend 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2
... plc (Nasdaq: JAZZ ) today announced that the ... Monday, February 27, 2011 at 4:30 p.m. EST/9:30 p.m. GMT. ... and review fourth quarter and full year 2011 financial results. ... accessed from the Investors section of the Jazz Pharmaceuticals, website ...
... PLEASANTON, Calif., Feb. 14, 2012  Thoratec Corporation (NASDAQ: ... circulatory support therapies to save, support and restore failing ... Leerink Swann 2012 Global Healthcare Conference on Thursday, February ... Investor Relations and Business Development, will provide an update ...
Cached Medicine Technology:
(Date:7/29/2014)... California (PRWEB) July 29, 2014 ... of the peer-reviewed journal Lipids in Health and ... value—of Nordic Naturals triglyceride-form best-selling Ultimate Omega®/ProOmega®. Consistently ... according to SPINS scan data, the product was ... to other omega-3 products in the marketplace. The ...
(Date:7/29/2014)... “Our years of experience with ... to insulate their homes properly simply due to ... heat transfer and conduction,” Clean Crawls says in ... released an article explaining exactly how heat ... bills. , To contact Clean Crawls for their ...
(Date:7/29/2014)... Bethesda, Maryland (PRWEB) July 29, 2014 ... has been named a 2014 ASAE Power of ... Flu-Focused," a public awareness campaign to encourage everyone age ... annually. , ASAE recognized NFID for its power ... drive awareness and action among consumers and professionals about ...
(Date:7/29/2014)... 2014 “Approximately 18% of our population ... common chronic illnesses,” Western Washington Medical Group says in ... for those suffering from allergies to seek medical attention. ... care each year in the United States,” they continue. ... of life for themselves, rather than seeking the appropriate ...
(Date:7/29/2014)... 29, 2014 The Eleventh Annual Business ... concluded with the $10,000 prize being presented to Ambika ... ) , The 11th Annual Summit was held on ... who can bring innovative products and services for the ... to have had such excellent array of young companies ...
Breaking Medicine News(10 mins):Health News:Study Shows Nordic Naturals® Triglyceride-Form Ultimate Omega®/ProOmega® More Effective Than Krill Oil, Salmon Oil, and Ethyl Ester Fish Oil 2Health News:Study Shows Nordic Naturals® Triglyceride-Form Ultimate Omega®/ProOmega® More Effective Than Krill Oil, Salmon Oil, and Ethyl Ester Fish Oil 3Health News:What’s The Point of Insulation? Clean Crawls Explains The Dangers of Heat Transfer in Recently Released Article 2Health News:National Foundation for Infectious Diseases Receives Top ASAE Honors for Keeping the Nation Flu-Focused 2Health News:Allergy Sufferers are Urged to Seek Medical Help in Recent Article by Western Washington Medical Group 2Health News:Allergy Sufferers are Urged to Seek Medical Help in Recent Article by Western Washington Medical Group 3Health News:Silicon Valley Boomer Venture Summit Names Bikanta Competition Winner 2
... DOMA Vector and DOMA Technologies to provide Record Conversion Services to more ... the Pacific. DOMA will convert millions of veteran treatment records from ... service to our veterans while reducing cost. , ... Virginia Beach, Va. ...
... DIEGO, May 7 Brandes Investment Partners, L.P. ("Brandes") ... submitted to Mitsui Sumitomo Insurance Group Holdings, Inc. (the ... on the Tokyo Stock Exchange, a proposal for a ... at the Company,s upcoming annual meeting of shareholders. ...
... weathering recession at national ALFA conferencePHILADELPHIA , ... executives today expressed confidence in the state of ... the conclusion of a national conference here.The executives ... far better than other businesses because it had ...
... Mobilization Campaign Urges Congress to Make Health Reform Work ... Hospital at Stanford is joining the National ... to launch a grassroots mobilization campaign asking Congress and ... for children. "Our hospital is extraordinarily proud ...
... WASHINGTON, May 7 The following is ... of the American Health Care Association (AHCA), Dave Kyllo, ... (NCAL) and Alan G. Rosenbloom, President of the Alliance ... the Obama Administration,s commitment to creating new jobs and ...
... May 7 Acting in response to concerns about ... Hotels and Resorts (TM), a privately held operator ... North America and Europe, today announced a three-phase program ... and provide reassurance about the safety of its facilities.(logo: ...
Cached Medicine News:Health News:Veterans Administration Awards Small Business' $13 Million Contract to Digitize Veterans Health Records 2Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 2Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 3Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 4Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 5Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 6Health News:Senior Living Executives Optimistic About Future 2Health News:Lucile Packard Children's Hospital at Stanford to Raise Its Voice for Kids in Health Care Reform Debate 2Health News:Lucile Packard Children's Hospital at Stanford to Raise Its Voice for Kids in Health Care Reform Debate 3Health News:Joint Statement from AHCA, NCAL, and the Alliance on the Obama Administration's FY 2010 Budget 2Health News:Dolce Hotels and Resorts Initiates Program to Mitigate H1N1 Flu Risk 2
The Biopro Cox comb cup is manufactured from titanium and is porous coated on the outside of the shell. The Cox comb cup accommodates a polyethylene insert....
The Plasmacup SC satisfies two important requirements: high primary stability and a low friction bearing surface....
... The integration of Trabecular Metal ... proven implant design results in a ... not only meets surgeon demands for ... provides a wide variety of shell ...
The cementless BiHAPro cup combines proven concepts with the latest innovations in cementless THR....
Medicine Products: